Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

600196.SS Gross Margin

The Gross Margin of Shanghai Fosun Pharmaceutical Group Co Ltd (600196.SS) is 47.83%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

600196.SS Gross Margin - Historical Value
Date Value
2024-12-31 47.83%
2023-12-31 47.54%
2022-12-31 47.09%
2021-12-31 47.97%
2020-12-31 55.47%
2019-12-31 59.57%
2018-12-31 58.34%
2017-12-31 58.85%
2016-12-31 53.81%
2015-12-31 49.78%
600196.SS Gross Margin - Peers Comparison
Ticker Name Value
000661.SZ Changchun High-Tech Industry Group Co Ltd 84.64%
603707.SS Nanjing King-friend Biochemical Pharmaceutical Co Ltd 46.17%
603858.SS Shandong Buchang Pharmaceuticals Co Ltd 59.04%
867.HK China Medical System Holdings Ltd 72.60%
002001.SZ Zhejiang Nhu Co Ltd 41.55%
002773.SZ Chengdu Kanghong Pharmaceutical Group Co Ltd 89.46%
600812.SS North China Pharmaceutical Co Ltd 31.84%
000739.SZ Apeloa Pharmaceutical Co Ltd 23.26%
002603.SZ Shijiazhuang Yiling Pharmaceutical Co Ltd 46.47%
002422.SZ Sichuan Kelun Pharmaceutical Co Ltd 51.35%
1093.HK CSPC Pharmaceutical Group Ltd 69.97%
600518.SS Kangmei Pharmaceutical Co Ltd 12.58%
600436.SS Zhangzhou Pientzehuang Pharmaceutical Co Ltd 42.63%
000513.SZ Livzon Pharmaceutical Group Inc 64.80%
002653.SZ Haisco Pharmaceutical Group Co Ltd 71.47%
600420.SS Shanghai Shyndec Pharmaceutical Co Ltd 37.94%
600521.SS Zhejiang Huahai Pharmaceutical Co Ltd 60.64%
600535.SS Tasly Pharmaceutical Group Co Ltd 66.94%
000538.SZ Yunnan Baiyao Group Co Ltd 27.77%
300558.SZ Betta Pharmaceuticals Co Ltd 81.38%
600079.SS Humanwell Healthcare Group Co Ltd 44.47%
002821.SZ Asymchem Laboratories Tianjin Co Ltd 41.55%
600085.SS Beijing Tongrentang Co Ltd 43.56%
600267.SS Zhejiang Hisun Pharmaceutical Co Ltd 43.80%
600380.SS Joincare Pharmaceutical Group Industry Co Ltd 62.13%
000999.SZ China Resources Sanjiu Medical & Pharmaceutical Co Ltd 51.36%
002019.SZ Yifan Pharmaceutical Co Ltd 46.79%
002294.SZ Shenzhen Salubris Pharmaceuticals Co Ltd 71.63%